Allocating Retained Earnings to R&D and Capital Expenditure
First written in FY2016. 7 of 9 entries say "Restated". Latest entry: 2026-06-03.
51 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
The policy of allocating retained earnings to research and development and capital investment has been continued. - FY2022RestatedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
The policy of allocating retained earnings to research and development and capital investment has been continued. - FY2021RestatedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
The policy of allocating retained earnings to research and development and capital investment has been continued. - FY2019RestatedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
The policy of allocating retained earnings to research and development and capital investment has been continued. - FY2017RestatedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
The policy of allocating retained earnings to research and development and capital investment has been continued. - FY2016First statedAnnual report
「Retained funds will be allocated to R&D investment in new products and technologies and capital investment to prepare for future business development and rapid technological innovation, thereby improving results and strengthening the Company’s operating base.」
Shareholder returns, future investment and strengthening the financial position are considered together when determining profit allocation.